Genus (LSE:GNS) - Aktienkurs, Nachrichten und Analyse

GNS Aktienübersicht

Genus plc ist als Tiergenetik-Unternehmen in Nordamerika, Lateinamerika, dem Vereinigten Königreich, dem übrigen Europa, dem Nahen Osten, Russland, Afrika und Asien tätig.

Über das Unternehmen

GNS fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	2/6
Financial Health	2/6
Dividends	3/6

Belohnungen

0.5% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 21.54% pro Jahr

Risikoanalyse

Bei unseren Risikoprüfungen wurden keine Risiken für GNS festgestellt.

Genus plc Wettbewerber

Bioventix

AIM:BVXP

UK£206.2m

Ergomed

AIM:ERGO

UK£701.1m

Hikma Pharmaceuticals

LSE:HIK

UK£4.5b

HUTCHMED (China)

AIM:HCM

UK£2.4b

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Genus
Historical stock prices
Current Share Price	UK£17.70
52 Week High	UK£25.44
52 Week Low	UK£14.78
Beta	0.35
1 Month Change	-4.84%
3 Month Change	-1.39%
1 Year Change	-27.70%
3 Year Change	-65.63%
5 Year Change	-31.92%
Change since IPO	1,211.11%

Aktuelle Nachrichten und Updates

Recent updates

Estimating The Fair Value Of Genus plc (LON:GNS)

Apr 20

Is Genus (LON:GNS) Using Too Much Debt?

Mar 25

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Mar 05

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

Feb 25

Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Jan 17

Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

Dec 10

We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Nov 03

Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Sep 09

Is Genus (LON:GNS) A Risky Investment?

Mar 29

Is Genus (LON:GNS) Using Too Much Debt?

Dec 21

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Nov 17

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Oct 25

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Oct 11

Genus' (LON:GNS) Dividend Will Be £0.217

Sep 11

A Look At The Fair Value Of Genus plc (LON:GNS)

Sep 09

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

May 31

Is Genus (LON:GNS) A Risky Investment?

Mar 29

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Feb 27

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 22

With EPS Growth And More, Genus (LON:GNS) Is Interesting

Oct 29

Here's Why Genus (LON:GNS) Can Manage Its Debt Responsibly

Oct 14

Genus (LON:GNS) Could Easily Take On More Debt

Apr 05

Is Genus' (LON:GNS) 235% Share Price Increase Well Justified?

Mar 18

Trade Alert: The Independent Non-Executive Chairman Of Genus plc (LON:GNS), Iain G. Ferguson, Has Just Spent UK£73k Buying 150% More Shares

Feb 28

I Ran A Stock Scan For Earnings Growth And Genus (LON:GNS) Passed With Ease

Feb 26

How Much Of Genus plc (LON:GNS) Do Institutions Own?

Feb 01

Genus plc (LON:GNS) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Dec 22

Have Genus plc (LON:GNS) Insiders Been Selling Their Stock?

Dec 05

Is Genus' (LON:GNS) Share Price Gain Of 195% Well Earned?

Nov 20

Aktionärsrenditen

	GNS	GB Biotechs	GB Markt
7D	-3.0%	-3.7%	-1.8%
1Y	-27.7%	-26.9%	4.2%

Rendite im Vergleich zur Industrie: GNS wie die Branche UK Biotechs , die im vergangenen Jahr eine Rendite von -27 erzielte.

Rendite vs. Markt: GNS hinter dem Markt UK zurück, der im vergangenen Jahr eine Rendite von 7 erzielte.

Preisvolatilität

Is GNS's price volatile compared to industry and market?
GNS volatility
GNS Average Weekly Movement	4.2%
Biotechs Industry Average Movement	6.0%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	11.3%
10% least volatile stocks in GB Market	2.8%

Stabiler Aktienkurs: GNS hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: GNSDie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1994	3,500	JK Kokke	www.genusplc.com

Genus plc ist als Tiergenetikunternehmen in Nordamerika, Lateinamerika, dem Vereinigten Königreich, dem übrigen Europa, dem Nahen Osten, Russland, Afrika und Asien tätig. Das Unternehmen ist in drei Segmenten tätig: Genus PIC, Genus ABS und Genus Forschung und Entwicklung. Unter der Marke PIC vertreibt das Unternehmen Zuchtschweine und Sperma zur Aufzucht von Schweinen mit verschiedenen Merkmalen für die Schweinefleischproduktion.

Genus plc's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Genus im Vergleich zum Marktanteil des Unternehmens?
GNS grundlegende Statistiken
Marktanteil	UK£1.17b
Gewinn(TTM)	UK£33.40m
Umsatz(TTM)	UK£673.10m

34.7x

Kurs-Gewinn-Verhältnis

1.7x

Kurs-Umsatz-Verhältnis

Ist GNS zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
GNS Gewinn- und Verlustrechnung (TTM)
Einnahmen	UK£673.10m
Kosten der Einnahmen	UK£429.10m
Bruttogewinn	UK£244.00m
Sonstige Ausgaben	UK£210.60m
Umsatz	UK£33.40m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

Sep 05, 2024

Gewinn per Aktie (EPS)	0.51
Bruttomarge	36.25%
Nettogewinnspanne	4.96%
Schulden/Eigenkapital-Verhältnis	40.7%

Wie hat sich GNS auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

1.8%

Aktuelle Dividendenrendite

63%

Ausschüttungsquote

GNS Aktienübersicht

Belohnungen

Risikoanalyse

Genus plc Wettbewerber

AIM:BVXP

UK£206.2m

AIM:ERGO

UK£701.1m

LSE:HIK

UK£4.5b

AIM:HCM

UK£2.4b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Price target decreased by 7.9% to UK£28.74

Estimating The Fair Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) Using Too Much Debt?

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 10% to UK£29.62

Recent updates

Price target decreased by 7.9% to UK£28.74

Estimating The Fair Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) Using Too Much Debt?

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 10% to UK£29.62

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

First half dividend of UK£0.10 announced

First half 2024 earnings released: EPS: UK£0.21 (vs UK£0.20 in 1H 2023)

Consensus EPS estimates fall by 23%

Investor sentiment deteriorates as stock falls 19%

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Genus Appoints Ralph Heuser as Non-Executive Director, with effect from 1 January 2024

Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

Genus plc to Report Fiscal Year 2024 Results on Sep 05, 2024

Genus plc Approves to Declare Final Dividend

We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Upcoming dividend of UK£0.22 per share at 1.4% yield

Full year 2023 earnings: EPS exceeds analyst expectations

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Executive Director exercised options and sold UK£194k worth of stock

Consensus EPS estimates fall by 19%

Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Full year 2023 earnings: EPS exceeds analyst expectations

Genus plc Announces Lykele Van Der Broek to Step Down from the Genus Board

AB Agri Ltd. completed the acquisition of National Milk Records plc (OFEX:NMRP) from Livestock Improvement Corporation Limited (NZSE:LIC), ICM Investment Management Limited, Genus plc (LSE:GNS), Custodial Capital Management Limited, High Street Partners, Ltd, and Working Capital Partners Ltd.

Price target decreased by 8.4% to UK£38.82

Now 20% undervalued after recent price drop

Price target decreased by 8.0% to UK£40.28

Is Genus (LON:GNS) A Risky Investment?

First half 2023 earnings released: EPS: UK£0.20 (vs UK£0.30 in 1H 2022)

Is Genus (LON:GNS) Using Too Much Debt?

Price target decreased to UK£40.14

Genus plc to Report Fiscal Year 2023 Results on Sep 07, 2023

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Investor sentiment improved over the past week

Upcoming dividend of UK£0.22 per share

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Genus' (LON:GNS) Dividend Will Be £0.217

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

A Look At The Fair Value Of Genus plc (LON:GNS)

Investor sentiment improved over the past week

Genus plc Proposes Final Dividend, Payable on 9 December 2022

Investor sentiment improved over the past week

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

Price target decreased to UK£46.05

Is Genus (LON:GNS) A Risky Investment?

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Genus plc Proposes Interim Dividend, Payable on March 31, 2022

Genus plc to Report First Half, 2022 Results on Feb 24, 2022

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Chairman recently bought UK£224k worth of stock

Upcoming dividend of UK£0.22 per share

With EPS Growth And More, Genus (LON:GNS) Is Interesting

Erträge & Einnahmen